Azafaros
Gisela Linthorst currently holds the position of Head of Patient Engagement and Advocacy at AZAFAROS B.V. Previously, Gisela served as Head Patient Advocacy Europe at MyoKardia and Director Patient Advocacy Rare Diseases Europe/Global at Sanofi Genzyme. With a background in nursing, Gisela has experience in setting up Patient Support Programs and homecare programs for patients with lysosomal storage disorders. Gisela has also worked as a Project Manager in various pharmaceutical companies and as a nurse specializing in oncology and hematology. Gisela's career has been focused on improving patient outcomes and incorporating the patient perspective in healthcare initiatives.
This person is not in any offices
Azafaros
Azafaros is developing new treatment options to help patients with rare metabolic disorders. Azafaros was founded in 2018 by a team of experienced industry professionals and scientists aspiring to address rare genetic metabolic disorders through a pipeline of oral small molecules with disease-modifying potential.